Sylvia Mae Hofer, RN in Freeman, SD - Registered Nurse

Sylvia Mae Hofer, RN is a Registered Nurse - Home Health based in Freeman, South Dakota. Sylvia Mae Hofer is licensed to practice in South Dakota (license number R021709) and her current practice location is 203 S Olive Dr, Freeman, South Dakota. She can be reached at her office (for appointments etc.) via phone at (605) 661-0377.

NPI number for Sylvia Mae Hofer is 1841908308 and her current mailing address is 203 S Olive Dr, Freeman, South Dakota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1841908308.

Contact Information

	Sylvia Mae Hofer, RN
	203 S Olive Dr, Freeman, SD 57029-2157
	(605) 661-0377
	Not Available

Provider's Profile

Full Name	Sylvia Mae Hofer
Gender	Female
Speciality	Registered Nurse - Home Health
Location	203 S Olive Dr, Freeman, South Dakota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1841908308
Provider Enumeration Date: 11/14/2022
Last Update Date: 11/14/2022

Medical Identifiers

Medical identifiers for Sylvia Mae Hofer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1841908308	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163WH0200X	Registered Nurse - Home Health	R021709 (South Dakota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sylvia Mae Hofer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sylvia Mae Hofer, RN 203 S Olive Dr, Freeman, SD 57029-2157 Ph: (605) 661-0377	Sylvia Mae Hofer, RN 203 S Olive Dr, Freeman, SD 57029-2157 Ph: (605) 661-0377

News Archive

Enrollment commences in multi-center clinical trial of CorMatrix ECM for Pericardial Closure

CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that Franciscan Alliance/St. Francis Heart Center in Indianapolis, Indiana is the first site to enroll a patient in the multi-center clinical trial of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation.

Germans panic and dump their cats as Serbia joins the bird flu list

According to an animal welfare society in Germany, hundreds of cats are being left at animal shelters following the disclosure earlier in the week that a cat on the island of Ruegen had died from the deadly bird flu.

Study shows unprecedented impact of COVID-19 on surgical care in Ontario

The estimated time to clear surgeries postponed in Ontario because of the coronavirus disease 2019 (COVID-19) pandemic is 84 weeks, with a target of 717 surgeries per week, according to a new modelling study in CMAJ.

Study to determine the outcomes and complications of ERCP in a community practice to appear in GIE journal

A new study from researchers in Minnesota found that endoscopic retrograde cholangiopancreatography (ERCP) performed in a community hospital setting results in complication rates that compare favorably with those of academic centers while achieving technical success at or above the performance levels recommended by the American Society for Gastrointestinal Endoscopy (ASGE)/American College of Gastroenterology (ACG) Task Force.

Rapid cooling procedures prior to catheterization reduce extent of myocardial infarction

After an acute myocardial infarction, patients treated with rapid lowering of body temperature by combined cold saline infusion and endovascular cooling had less heart muscle damage and reduced incidence of heart failure. Therapeutic hypothermia was especially protective against heart muscle damage in patients with a large area of myocardium at risk according to an analysis of two clinical trials published in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Sylvia Mae Hofer, RN - Registered Nurse in Freeman, SD